Journal Home > Volume 5 , Issue 1

In the present study, we evaluated the changes in autophagy after hyperbaric oxygen (HBO) treatment for traumatic brain injury (TBI) and investigated whether autophagy takes part in the neuroprotection after HBO treatment. Male Sprague Dawley rats were assigned to four groups randomly: sham injury, sham injury and HBO, TBI, and TBI and HBO. The HBO rats received HBO treatment for 100 min immediately after injury. Rats were sacrificed at 24 h after the brain injury and the levels of cleaved caspase-3 and the number of terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-positive cells in the injured cortex were measured to determine cell death. The expression levels of autophagy-associated proteins were measured by immunohistochemistry and Western blotting to assess changes in autophagy. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-positive cell density and cleaved caspase-3 expression were increased 24 h after TBI. These increases were suppressed by post-TBI HBO treatment. Immunohistochemistry and Western blotting of autophagy-associated proteins showed that TBI can induce autophagy and that HBO treatment can further upregulate the expression of autophagy makers, as shown by an increase in LC3, ATG-5, and Beclin-1 expression and reduction in P62 expression. In conclusion, HBO treatment can reduce apoptosis and further upregulate autophagy in the injured cortex after brain injury, and the autophagy pathway may take part in the neuroprotection provided by HBO treatment for TBI.


menu
Abstract
Full text
Outline
About this article

Neuroprotection of hyperbaric oxygen treatment for traumatic brain injury involving autophagy pathway in rats

Show Author's information Wen-Chao LiuLiang WenHao WangJiang-Biao GongTian-Xiang ZhanYuan-Yuan MengXiao-Feng Yang( )
Department of Neurosurgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People’s Republic of China

Abstract

In the present study, we evaluated the changes in autophagy after hyperbaric oxygen (HBO) treatment for traumatic brain injury (TBI) and investigated whether autophagy takes part in the neuroprotection after HBO treatment. Male Sprague Dawley rats were assigned to four groups randomly: sham injury, sham injury and HBO, TBI, and TBI and HBO. The HBO rats received HBO treatment for 100 min immediately after injury. Rats were sacrificed at 24 h after the brain injury and the levels of cleaved caspase-3 and the number of terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-positive cells in the injured cortex were measured to determine cell death. The expression levels of autophagy-associated proteins were measured by immunohistochemistry and Western blotting to assess changes in autophagy. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-positive cell density and cleaved caspase-3 expression were increased 24 h after TBI. These increases were suppressed by post-TBI HBO treatment. Immunohistochemistry and Western blotting of autophagy-associated proteins showed that TBI can induce autophagy and that HBO treatment can further upregulate the expression of autophagy makers, as shown by an increase in LC3, ATG-5, and Beclin-1 expression and reduction in P62 expression. In conclusion, HBO treatment can reduce apoptosis and further upregulate autophagy in the injured cortex after brain injury, and the autophagy pathway may take part in the neuroprotection provided by HBO treatment for TBI.

Keywords: hyperbaric oxygen treatment, autophagy, apoptosis, traumatic brain injury, neuroprotective effect

References(46)

1.
Unterberg AW, Stover J, Kress B, Kiening KL. Edema and brain trauma. Neuroscience .2004;129(4):1021-1029.
2.
Cernak I, Noble-Haeusslein LJ. Traumatic brain injury: an overview of pathobiology with emphasis on military populations. J Cereb Blood Flow Metab .2010;30(2):255-266.
3.
Loane DJ, Faden AI. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci .2010;31(12):596-604.
4.
Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth .2007;99(1):4-9.
5.
Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol .2008;7(8):728-741.
6.
Clark RS, Bayir H, Chu CT, Alber SM, Kochanek PM, Watkins SC. Autophagy is increased in mice after traumatic brain injury and is detectable in human brain after trauma and critical illness. Autophagy .2008;4(1):88-90.
7.
Liu CL, Chen S, Dietrich D, Hu BR. Changes in autophagy after traumatic brain injury. J Cereb Blood Flow Metab .2008;28(4):674-683.
8.
Luo CL, Li BX, Li QQ, et al.Autophagy is involved in traumatic brain injury-induced cell death and contributes to functional outcome deficits in mice. Neuroscience .2011;184:54-63.
9.
Jin Y, Lin Y, Feng JF, Jia F, Gao GY, Jiang JY.Moderate hypothermia significantly decreases hippocampal cell death involving autophagy pathway after moderate traumatic brain injury. J Neurotrauma .2015;32(14):1090-1100.
10.
Gordy C, He YW. The crosstalk between autophagy and apoptosis: where does this lead? Protein Cell .2012;3(1):17-27.
11.
Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol .2007;8(11):931-937.
12.
Jing CH, Wang L, Liu PP, Wu C, Ruan D, Chen G.Autophagy activation is associated with neuroprotection against apoptosis via a mitochondrial pathway in a rat model of subarachnoid hemorrhage. Neuroscience .2012;213:144-153.
13.
Balduini W, Carloni S, Buonocore G. Autophagy in hypoxia-ischemia induced brain injury. J Matern Fetal Neonatal Med .2012;25 (Suppl 1):30-34.
14.
Carloni S, Buonocore G, Longini M, Proietti F, Balduini W. Inhibition of rapamycin-induced autophagy causes necrotic cell death associated with Bax/Bad mitochondrial translocation. Neuroscience .2012;203:160-169.
15.
Son JH, Shim JH, Kim KH, Ha JY, Han JY. Neuronal autophagy and neurodegenerative diseases. Exp Mol Med .2012;44(2):89-98.
16.
Zhang YB, Li SX, Chen XP, et al. Autophagy is activated and might protect neurons from degeneration after traumatic brain injury. Neurosci Bull .2008;24(3):143-149.
17.
Lai Y, Hickey RW, Chen Y, et al.Autophagy is increased after traumatic brain injury in mice and is partially inhibited by the antioxidant gamma-glutamylcysteinyl ethyl ester. J Cereb Blood Flow Metab .2008;28(3):540-550.
18.
Huang L, Obenaus A. Hyperbaric oxygen therapy for traumatic brain injury. Med Gas Res .2011;1:21.
19.
Zhang Y, Yang Y, Tang H, et al.Hyperbaric oxygen therapy ameliorates local brain metabolism, brain edema and inflammatory response in a blast-induced traumatic brain injury model in rabbits. Neurochem Res .2014;39(5):950-960.
20.
Geng F, Ma Y, Xing T, Zhuang X, Zhu J, Yao L.Effects of hyperbaric oxygen therapy on inflammasome signaling after traumatic brain injury. Neuroimmunomodulation .2016;23(2):122-129.
21.
Hadanny A, Efrati S. The efficacy and safety of hyperbaric oxygen therapy in traumatic brain injury. Expert Rev Neurother .2016;16(4):359-360.
22.
McIntosh TK, Vink R, Noble L, et al.Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model. Neuroscience .1989;28(1):233-244.
23.
Clark RS, Kochanek PM, Chen M, et al.Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J .1999;13(8):813-821.
24.
Tashlykov V, Katz Y, Gazit V, Zohar O, Schreiber S, Pick CG.Apoptotic changes in the cortex and hippocampus following minimal brain trauma in mice. Brain Res .2007;1130(1):197-205.
25.
Rink A, Fung KM, Trojanowski JQ, Lee VM, Neugebauer E, McIntosh TK.Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am J Pathol .1995;147(6):1575-1583.
26.
Newcomb JK, Zhao X, Pike BR, Hayes RL. Temporal profile of apoptotic-like changes in neurons and astrocytes following controlled cortical impact injury in the rat. Exp Neurol .1999;158(1):76-88.
27.
Slemmer JE, Zhu C, Landshamer S, et al.Causal role of apoptosis-inducing factor for neuronal cell death following traumatic brain injury. Am J Pathol .2008;173(6):1795-1805.
28.
Raghupathi R, Graham DI, McIntosh TK. Apoptosis after traumatic brain injury. J Neurotrauma .2000;17(10):927-938.
29.
Raghupathi R, Conti AC, Graham DI, et al.Mild traumatic brain injury induces apoptotic cell death in the cortex that is preceded by decreases in cellular Bcl-2 immunoreactivity. Neuroscience .2002;110(4):605-616.
30.
Diskin T, Tal-Or P, Erlich S, et al. Closed head injury induces upregulation of Beclin 1 at the cortical site of injury. J Neurotrauma. 2005;22(7):750-762.
31.
Galluzzi L, Bravo-San Pedro JM, Blomgren K, Kroemer G. Autophagy in acute brain injury. Nat Rev Neurosci .2016;17(8):467-484.
32.
Lai YC, Hickey RW, Chen Y, et al.Autophagy is increased after traumatic brain injury in mice and is partially inhibited by the antioxidant gamma-glutamylcysteinyl ethyl ester. J Cerebr Blood F Met .2008;28(3):540-550.
33.
Suzuki K, Ohsumi Y. Molecular machinery of autophagosome formation in yeast, Saccharomyces cerevisiae. FEBS Lett. 2007;581(11):2156-2161.
34.
Mizushima N, Yamamoto A, Hatano M, et al. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol. 2001;152(4):657-668.10.1083/jcb.152.4.657
35.
Tanida I, Ueno T, Kominami E. LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol. 2004;36(12):2503-2518.
36.
Erlich S, Alexandrovich A, Shohami E, Pinkas-Kramarski R. Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis .2007;26(1):86-93.
37.
Feng Y, Gao J, Cui Y, et al.Neuroprotective effects of resatorvid against traumatic brain injury in rat: involvement of neuronal autophagy and TLR4 signaling pathway. Cell Mol Neurobiol .2017;37(1):155-168.
38.
Yao J, Zheng K, Zhang X. Rosiglitazone exerts neuroprotective effects via the suppression of neuronal autophagy and apoptosis in the cortex following traumatic brain injury. Mol Med Rep .2015;12(5):6591-6597.
39.
Zhang QX, Chang Q, Cox RA, Gong XM, Gould LJ. Hyperbaric oxygen attenuates apoptosis and decreases inflammation in an ischemic wound model. J Invest Dermatol .2008;128(8):2102-2112.
40.
Liu Z, Jiao QF, You C, Che YJ, Su FZ. Effect of hyperbaric oxygen on cytochrome C, Bcl-2 and Bax expression after experimental traumatic brain injury in rats. Chin J Traumatol .2006;9(3):168-174.
41.
Palzur E, Zaaroor M, Vlodausky E, Milman F, Soustiel JF. Neuroprotective effect of hyperbaric oxygen therapy in brain injury is mediated by preservation of mitochondrial membrane properties. Brain Res .2008;1221:126-133.
42.
Weber SU, Koch A, Kankeleit J, et al. Hyperbaric oxygen induces apoptosis via a mitochondrial mechanism. Apoptosis .2009;14(1):97-107.
43.
Chen X, Duan XS, Xu LJ, et al.Interleukin-10 mediates the neuroprotection of hyperbaric oxygen therapy against traumatic brain injury in mice. Neuroscience .2014;266:235-243.
44.
Yang J, Liu X, Bhalla K, et al.Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science .1997;275(5303):1129-1132.
45.
Zalckvar E, Berissi H, Eisenstein M, Kimchi A. Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-XL. Autophagy .2009;5(5):720-722.
46.
Wei Y, Pattingre S, Sinha S, Bassik M, Levine B. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol Cell .2008;30(6):678-688.
Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Published: 07 April 2017
Issue date: December 2017

Copyright

© 2017 The Author(s).

Acknowledgements

This project was supported by grants from the National Natural Science Foundation of China (81470052 and 81200955).

Rights and permissions

© 2017 Liu et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

Return